209 related articles for article (PubMed ID: 34383966)
1. Systematic review with meta-analysis: the effects of family history on the risk of Barrett's oesophagus and oesophageal adenocarcinoma.
Peters Y; van Grinsven E; Siersema PD
Aliment Pharmacol Ther; 2021 Oct; 54(7):868-879. PubMed ID: 34383966
[TBL] [Abstract][Full Text] [Related]
2. Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus.
Holmberg D; Ness-Jensen E; Mattsson F; El-Serag HB; Lagergren J
Eur J Cancer; 2017 Apr; 75():41-46. PubMed ID: 28214656
[TBL] [Abstract][Full Text] [Related]
3. Systematic review with meta-analysis: prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients.
Tan MC; Mansour N; White DL; Sisson A; El-Serag HB; Thrift AP
Aliment Pharmacol Ther; 2020 Jul; 52(1):20-36. PubMed ID: 32452599
[TBL] [Abstract][Full Text] [Related]
4. Global prevalence of Barrett's oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysis.
Eusebi LH; Cirota GG; Zagari RM; Ford AC
Gut; 2021 Mar; 70(3):456-463. PubMed ID: 32732370
[TBL] [Abstract][Full Text] [Related]
5. NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.
Masclee GM; Coloma PM; Spaander MC; Kuipers EJ; Sturkenboom MC
BMJ Open; 2015 Jan; 5(1):e006640. PubMed ID: 25633286
[TBL] [Abstract][Full Text] [Related]
6. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis.
Singh S; Garg SK; Singh PP; Iyer PG; El-Serag HB
Gut; 2014 Aug; 63(8):1229-37. PubMed ID: 24221456
[TBL] [Abstract][Full Text] [Related]
7. Demographic and phenotypic features of 70 families segregating Barrett's oesophagus and oesophageal adenocarcinoma.
Drovdlic CM; Goddard KA; Chak A; Brock W; Chessler L; King JF; Richter J; Falk GW; Johnston DK; Fisher JL; Grady WM; Lemeshow S; Eng C
J Med Genet; 2003 Sep; 40(9):651-6. PubMed ID: 12960209
[TBL] [Abstract][Full Text] [Related]
8. MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma.
Fisher OM; Levert-Mignon AJ; Lord SJ; Lee-Ng KK; Botelho NK; Falkenback D; Thomas ML; Bobryshev YV; Whiteman DC; Brown DA; Breit SN; Lord RV
Br J Cancer; 2015 Apr; 112(8):1384-91. PubMed ID: 25867265
[TBL] [Abstract][Full Text] [Related]
9. The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma.
den Hoed CM; van Blankenstein M; Dees J; Kuipers EJ
Br J Cancer; 2011 Jul; 105(2):200-5. PubMed ID: 21673678
[TBL] [Abstract][Full Text] [Related]
10. Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study.
Bhat SK; McManus DT; Coleman HG; Johnston BT; Cardwell CR; McMenamin U; Bannon F; Hicks B; Kennedy G; Gavin AT; Murray LJ
Gut; 2015 Jan; 64(1):20-5. PubMed ID: 24700439
[TBL] [Abstract][Full Text] [Related]
11. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis.
Desai TK; Krishnan K; Samala N; Singh J; Cluley J; Perla S; Howden CW
Gut; 2012 Jul; 61(7):970-6. PubMed ID: 21997553
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett's Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON Consortium.
Lagergren K; Ek WE; Levine D; Chow WH; Bernstein L; Casson AG; Risch HA; Shaheen NJ; Bird NC; Reid BJ; Corley DA; Hardie LJ; Wu AH; Fitzgerald RC; Pharoah P; Caldas C; Romero Y; Vaughan TL; MacGregor S; Whiteman D; Westberg L; Nyren O; Lagergren J
PLoS One; 2015; 10(9):e0138738. PubMed ID: 26406593
[TBL] [Abstract][Full Text] [Related]
13. The incidence of Barrett's oesophagus and oesophageal adenocarcinoma in the United Kingdom and The Netherlands is levelling off.
Masclee GM; Coloma PM; de Wilde M; Kuipers EJ; Sturkenboom MC
Aliment Pharmacol Ther; 2014 Jun; 39(11):1321-30. PubMed ID: 24738722
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and prevention of oesophageal adenocarcinoma.
Ness-Jensen E
Scand J Gastroenterol; 2022 Aug; 57(8):891-895. PubMed ID: 35234549
[TBL] [Abstract][Full Text] [Related]
15. The evolution and outcome of surveillance of Barrett's oesophagus over four decades in a UK District General Hospital.
Royston C; Caygill C; Charlett A; Bardhan KD
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1365-1373. PubMed ID: 27571366
[TBL] [Abstract][Full Text] [Related]
16. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis.
Kastelein F; van Olphen S; Steyerberg EW; Sikkema M; Spaander MC; Looman CW; Kuipers EJ; Siersema PD; Bruno MJ; de Bekker-Grob EW;
Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191
[TBL] [Abstract][Full Text] [Related]
17. Toenail trace element status and risk of Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study.
O'Rorke MA; Cantwell MM; Abnet CC; Brockman AJ; Murray LJ;
Int J Cancer; 2012 Oct; 131(8):1882-91. PubMed ID: 22262413
[TBL] [Abstract][Full Text] [Related]
18. Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression.
Kastelein F; van Olphen SH; Steyerberg EW; Spaander MC; Bruno MJ;
Gut; 2016 Apr; 65(4):548-54. PubMed ID: 25903690
[TBL] [Abstract][Full Text] [Related]
19. Adam, Eve and the reflux enigma: age and sex differences across the gastro-oesophageal reflux spectrum.
Royston C; Bardhan KD
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):634-639. PubMed ID: 28151751
[TBL] [Abstract][Full Text] [Related]
20. Barrett's Oesophagus Surveillance versus endoscopy at need Study (BOSS): protocol and analysis plan for a multicentre randomized controlled trial.
Old O; Moayyedi P; Love S; Roberts C; Hapeshi J; Foy C; Stokes C; Briggs A; Jankowski J; Barr H;
J Med Screen; 2015 Sep; 22(3):158-64. PubMed ID: 25767103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
